Dr. Cultrera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1400 N US Highway 441
Suite 540
Lady Lake, FL 32159Phone+1 352-753-9777Fax+1 352-753-9781
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2006 - 2009
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2003 - 2006
- University of Miami Leonard M. Miller School of MedicineClass of 2003
Certifications & Licensure
- FL State Medical License 2009 - 2025
- TX State Medical License 2006 - 2009
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2013-2014
Clinical Trials
- Safety Study of ON 013105 in Lymphoma and Acute Lymphoid Leukemia Start of enrollment: 2009 Nov 01
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer Start of enrollment: 2015 Jul 13
- A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract Cancer Start of enrollment: 2015 Jul 29
- Join now to see all
Publications & Presentations
PubMed
- 184 citationsRamucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a m...Roy S. Herbst, Hendrik-Tobias Arkenau, Rafael Santana-Davila, Emiliano Calvo, Luis Paz-Ares
The Lancet. Oncology. 2019-08-01 - 83 citationsDiffuse large B-cell lymphoma: current strategies and future directions.Jennifer L. Cultrera, Samir Dalia
Cancer Control. 2012-07-01 - 20 citationsRamucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.Ian Chau, Nicolas Penel, Andres O. Soriano, Hendrik-Tobias Arkenau, Jennifer L. Cultrera
Cancers. 2020-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: